SRTANasdaqServices-Health ServicesFiscal year ends December 31
Strata Critical Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$4.54+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $391.41M
- P/E (TTM)
- 8.9
- Dividend yield
- –
Strata Critical Medical, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Logistics | $176.79M | $146.82M | – | – | – | – | 89.7% | +20.4% |
| Clinical | $20.35M | $0 | – | – | – | – | 10.3% | – |
| Passenger | – | $101.88M | $98.58M | $44.13M | – | – | – | – |
| Medical Segment | – | $146.82M | $126.60M | $6.40M | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | YoY |
|---|---|---|---|---|---|---|---|
| Passenger | – | – | -$33.50M | $404.00K | – | – | – |
| Medical Segment | – | – | -$1.39M | $446.00K | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Short Distance | – | – | – | $22.25M | $9.47M | $26.04M | – | – |
| Jet and Other | – | – | – | $1.93M | $492.00K | $85.00K | – | – |
| MediMobility Organ Transport | – | – | – | $26.35M | $13.48M | $5.07M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | – | $218.75M | $190.74M | $50.53M | – | – | – | – |
| Other | – | $29.95M | $34.44M | $0 | – | – | – | – |
From the segment and revenue-disaggregation notes of Strata Critical Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.